About Arrhythmia Alliance
Arrhythmia Alliance (A-A) is a 501(c)(3) non-profit organization with the aim of working together to improve the diagnosis, treatment and quality of life for all those affected by arrhythmias.
A-A is a coalition of charities, patient groups, patients, caregivers, medical groups and allied professionals. Although these groups remain independent, they work together under the A-A umbrella to promote timely and effective diagnosis and treatment of arrhythmias.
Our Working Objections
- To bring together member charities, healthcare professionals, commissioners and their allies
- To advance the concerns and needs of all our members
- To develop the knowledge and skills base of medical professionals and professions allied to medicine
- To cultivate multi-center and multi-disciplinary research
- To prevent sudden cardiac death in vulnerable groups
- To promote the value and need for cardiac pacing, implantable defibrillators, catheter ablation and other treatments for arrhythmias
- To prevent misdiagnosis in patients suffering from arrhythmias and transient loss of consciousness (T-LoC)
- To assess and quantify unmet need among those affected by arrhythmias
- To promote centers of excellence for arrhythmia diagnosis and treatment
- To secure better care, leading to a better quality of life, for individuals with arrhythmias
Founder, CEO & Trustee
Trudie Lobban MBE
Prof. John Camm
Nigel Breakwell - Board Chair
Nigel Breakwell became Chair at the beginning of 2017, having previously been a Board member since 2016. He is an Executive Committee member, Arrhythmia Alliance UK, and Special Projects Director for the Charity with a focus on Policy & Communications. He leads the A-A secretariat for the All Party Parliamentary Groups on Arrhythmias and Atrial Fibrillation.
He has worked closely with A-A since 2012, first working with Trudie Lobban, to create the Hearts & Goals initiative (with SCA survivor, former soccer player, Fabrice Muamba), then with Bernard Gallacher (famous Ryder Cup golfer, SCA survivor) and his family – to set up and launch the Arrhythmia Alliance Bernard Gallacher Defibs campaign in 2014. He has over three decades of experience in healthcare, and over two decades in communications, having begun his pharmaceutical career in the mid-80s at Sanofi, in sales and marketing, followed by roles in sales, marketing, and external affairs at MSD UK, a marketing company of Merck Inc.
Daniel Beach is a European Client Leader at Omnicom, a global marketing and corporate communications holding company. He is a communications strategist with over 20 years of experience and a strong track record of managing domestic and international communication teams. Previously he has served as the Director of Communications and Strategy for Arrhythmia Alliance, the AF Association and STARS. Additional to his previous position, Beach serves as a co-author and publisher for the AF Healthcare Pioneers report. Mr. Beach has remained as a board member since 2006.
Hugh Calkins, MD
In 2017, Hugh Calkins became an Arrhythmia Alliance board member.
Dr. Calkins, director of the Electrophysiology Laboratory and Arrhythmia Service at Johns Hopkins Hospital and The Nicholas J. Fortuin M.D. Professor of Cardiology, is internationally recognized as an expert on catheter ablation, atrial fibrillation, syncope, and arrhythmia management. Dr. Calkins has published more than 600 articles and book chapters on a large variety of cardiac arrhythmias. His research has focused predominantly on catheter ablation, atrial fibrillation, syncope, and arrhythmogenic right ventricular dysplasia. Dr. Calkins has also written extensively on most aspects of heart rhythm disorders and their treatment. He was the lead author on the 2007, 2012, and 2017 Consensus Document on Catheter and Surgical Ablation of Atrial Fibrillation. He is a past president of the Heart Rhythm Society
Diana Reindl, PhD, CHES
In 2017, Diana Reindl became an Arrhythmia Alliance board member.
Dr. Diana Reindl, currently the Program Coordinator of B.S. in Health Promotion at the University of South Carolina- Beaufort, received her doctorate in Health Education from the University of Toledo with a minor in research design and statistics. She presently serves as a Certified Health Education Specialists and has yielded several years of experience as a researcher specialist preparing reports and developing evaluation research designs for The Ohio State University. Over the years, Dr. Reindl has attained maximum amounts of awards, preformed professional presentations and contributed to an extensive amount of publications.
With extensive education and training Joseph McCullough is an Arrhythmia Alliance board member. He has experience in developing ethical business culture along with global management experience including strategy development, operations and sales execution. Joseph has been successful in the development and execution of both global sales, local sales and marketing strategies.
He has worked for world renowned organizations and received multiple accomplishments such as introduced the AICD into the U.S. Market, initiated the development of the U.S. ICD market through education programs and more than doubled the bradycardia market share in the U.S.
Trudie Lobban MBE